Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Carisma Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +5 vs. Q3 2024
- Shares held
- 5.62M
- +1.67M (+42.2%) vs. Q3 2024
- Total value
- $2.35M
- −$1.53M (−39.3%) vs. Q3 2024
- New holders
- 14
- 5 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 3 | $47.9K |
| Q4 2025 | 7 | $67.0K |
| Q3 2025 | 33 | $842.6K |
| Q2 2025 | 36 | $1.56M |
| Q1 2025 | 37 | $1.73M |
| Q4 2024 | 41 | $2.35M |
| Q3 2024 | 37 | $5.11M |
| Q2 2024 | 53 | $9.28M |
| Q1 2024 | 51 | $19.3M |
| Q4 2023 | 50 | $26.4M |
| Q3 2023 | 58 | $39.6M |
| Q2 2023 | 53 | $84.0M |
| Q1 2023 | 37 | $17.3M |
| Q4 2022 | 71 | $19.8M |
| Q3 2022 | 69 | $11.0M |
| Q2 2022 | 74 | $23.1M |
| Q1 2022 | 84 | $26.4M |
| Q4 2021 | 93 | $39.1M |
| Q3 2021 | 103 | $44.5M |
| Q2 2021 | 106 | $305.9M |
| Q1 2021 | 76 | $104.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Merck & Co., Inc. | 1,473,240 | $617.0K | 0.24% | +1,473,240 | New |
| Vanguard Group Inc | 1,418,848 | $594.5K | 0.00% | −29,399−2.0% | Reduced |
| AJU IB Investment Co., Ltd. | 718,332 | $300.8K | 0.29% | +718,332 | New |
| Barclays PLC | 549,305 | $230.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 408,147 | $170.9K | 0.00% | −417−0.1% | Reduced |
| Geode Capital Management, LLC | 259,184 | $108.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 231,357 | $96.9K | 0.00% | +24,600+11.9% | Added |
| Millennium Management LLC | 120,157 | $50.3K | 0.00% | −22,365−15.7% | Reduced |
| State Street Corp | 85,106 | $35.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 69,888 | $29.3K | 0.00% | −5,563−7.4% | Reduced |
| HRT Financial LP | 36,902 | $15.0K | 0.00% | +36,902 | New |
| Bridgeway Capital Management, LLC | 30,988 | $13.0K | 0.00% | +550+1.8% | Added |
| Empowered Funds, LLC | 30,988 | $13.0K | 0.00% | +550+1.8% | Added |
| UBS Group AG | 24,301 | $10.2K | 0.00% | +24,083+11,047.2% | Added |
| Blodgett Wealth Advisors, LLC | 24,001 | $10.1K | 0.01% | −1,000−4.0% | Reduced |
| Goldman Sachs Group Inc | 21,381 | $8.95K | 0.00% | +21,381 | New |
| LPL Financial LLC | 20,895 | $8.75K | 0.00% | +20,895 | New |
| Virtu Financial LLC | 17,327 | $7.00K | 0.00% | +17,327 | New |
| Dynamic Financial Group | 15,350 | $6.43K | 0.01% | +15,350 | New |
| Stratos Wealth Partners, LTD. | 12,200 | $5.11K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,432 | $4.79K | 0.00% | +11,432 | New |
| Baader Bank INC | 11,804 | $4.42K | 0.00% | +11,804 | New |
| Tower Research Capital LLC (TRC) | 7,827 | $3.28K | 0.00% | +3,303+73.0% | Added |
| Bank of America Corp | 7,277 | $3.04K | 0.00% | −4−0.1% | Reduced |
| Morgan Stanley | 5,685 | $2.38K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 4,973 | $2.08K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,230 | $934 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 921 | $386 | 0.00% | 00.0% | Unchanged |
| Union Bancaire Privee, UBP SA | 535 | $227 | 0.00% | +535 | New |
| Bank & Trust Co | 525 | $220 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 467 | $196 | 0.00% | +467 | New |
| Peoples Bank | 250 | $102 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 206 | $86 | 0.00% | 00.0% | Unchanged |
| ORG Partners LLC | 200 | $83 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 150 | $63 | 0.00% | +150 | New |
| Advisor Group Holdings, Inc. | 142 | $59 | 0.00% | 00.0% | Unchanged |
| Medallion Wealth Advisors, LLC | 100 | $31 | 0.00% | +100 | New |
| National Bank of Canada | 50 | $21 | 0.00% | −115−69.7% | Reduced |
| Harbour Investments, Inc. | 37 | $15 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 31 | $13 | 0.00% | +31 | New |
| Citigroup Inc | 10 | $4 | 0.00% | 00.0% | Unchanged |
| TPG GP A, LLC | 0 | $0 | 0.00% | −561,442−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −34,861−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,141−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,584−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −736−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| McMahon Financial Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Trustees of the University of Pennsylvania | – | – | – | – | Not filed |